Jason Throne - 27 Jun 2024 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
Chief Legal Officer
Signature
/s/ Jason Throne
Issuer symbol
IDYA
Transactions as of
27 Jun 2024
Net transactions value
+$415,587
Form type
4
Filing time
27 Jun 2024, 18:47:10 UTC
Previous filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDYA Common Stock Options Exercise $85,696 +6,424 +64% $13.34 16,424 27 Jun 2024 Direct
transaction IDYA Common Stock Options Exercise $329,891 +47,060 +287% $7.01 63,484 27 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (Right to Buy) Options Exercise $0 -6,424 -13% $0.000000 41,186 27 Jun 2024 Common Stock 6,424 $13.34 Direct F1
transaction IDYA Stock Option (Right to Buy) Options Exercise $0 -47,060 -97% $0.000000 1,360 27 Jun 2024 Common Stock 47,060 $7.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from July 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F2 The shares subject to the option are fully vested and exercisable.